There's good news for North American women who are at low risk for complications and want to give birth at home.
There's good news for North American women who are at low risk for complications and want to give birth at home: Home births aided by a certified professional midwife apparently involve less medical intervention and cause less intrapartum and neonatal mortality-similar to that of low-risk hospital births-according to a recent prospective cohort study.
The study involved 5,418 women who planned to deliver at home. Of those, 655 (12.1%) were transferred to a hospital when labor began, 254 (4.7%) received an epidural, 116 (2.1%) received an episiotomy, 57 (1.0%) required forceps for delivery, 32 (0.6%) required vacuum extraction, and 200 (3.7%) required cesarean delivery. The intrapartum and neonatal mortality was 1.7 deaths per 1,000 planned home births, which was similar to the rate reported in other studies of home births and to low-risk hospital births. No mothers in the study who delivered at home died.
Worth noting is the fact that an uncomplicated vaginal birth in a hospital in the US cost on average three times as much as a birth at home with a midwife.
Link between prenatal air pollution and reduced lung function in offspring reported
July 25th 2024Higher prenatal exposure to PM2.5 pollution is associated with reduced lung volume and airflow limitation in children, highlighting the critical impact of air pollution on in utero lung development.
Read More
Cut costs observed from out-of-home care in children with prenatal substance exposure
July 24th 2024A recent study reveals that while children exposed to maternal substance use face higher hospital costs up to age 20 years, out-of-home care significantly mitigates this financial burden.
Read More
Global progress in neonatal tetanus elimination from 2000 to 2022
July 18th 2024Incorporating maternal and neonatal tetanus elimination strategies into national immunization activities is crucial for sustaining elimination and reducing neonatal mortality worldwide, as highlighted by the latest CDC report.
Read More
PreTRM test shows efficacy in reducing severe neonatal morbidity and mortality
July 18th 2024The PreTRM test, a blood-based biomarker test for predicting preterm birth risk, has demonstrated significant efficacy in lowering severe neonatal morbidity and mortality, as reported by Sera Prognostics Inc.
Read More